RxDoctor Payments Data

Vincent Dubesky

Physician Assistant · Lancaster, PANPI 1235878927

Payments from drug & device makers

$7,354in general payments, 2019–2025

Across 350 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Otsuka America Pharmaceutical, Inc.$978
  • Teva Pharmaceuticals USA, Inc.$882
  • AbbVie$784
  • Neurocrine Biosciences, Inc.$590
  • Johnson & Johnson$535
  • plus $3K from 11 others

What the payments were for

  • Food & beverage$7,04596%
  • Education$3094%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,354 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl99$128,721
Abilify MaintenaAripiprazole35$87,218
LatudaLurasidone Hcl39$74,289
Abilify AsimtufiiAripiprazole12$63,893
AristadaAripiprazole Lauroxil15$51,791
CaplytaLumateperone Tosylate12$20,313
RexultiBrexpiprazole12$16,618
LybalviOlanzapine/Samidorphan Malate15$13,528
TrintellixVortioxetine Hydrobromide20$13,197
Lurasidone Hcl52$9,780
Aripiprazole157$7,611
Fluvoxamine Maleate ErFluvoxamine Maleate13$5,340
Clozapine141$3,759
Olanzapine162$3,332
Venlafaxine Hcl ErVenlafaxine Hcl137$3,318

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti$978$167,72959 claims
AbbVieVraylar$784$128,72199 claims
Sunovion Pharmaceuticals Inc.Latuda$21$74,28939 claims
Alkermes, Inc.Aristada, Lybalvi$510$65,31930 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,073$20,31312 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$202$13,19720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →